MENU
+Compare
GDTC
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$1.93
Change
+$0.03 (+1.58%)
Capitalization
22.65M

GDTC CytoMed Therapeutics Limited Forecast, Technical & Fundamental Analysis

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers... Show more

GDTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GDTC with price predictions
Sep 05, 2025

GDTC in +0.25% Uptrend, advancing for three consecutive days on September 02, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where GDTC advanced for three days, in of 93 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GDTC's RSI Oscillator exited the oversold zone, of 8 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 25, 2025. You may want to consider a long position or call options on GDTC as a result. In of 48 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GDTC just turned positive on August 15, 2025. Looking at past instances where GDTC's MACD turned positive, the stock continued to rise in of 26 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 26 cases where GDTC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

GDTC moved below its 50-day moving average on September 03, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GDTC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GDTC broke above its upper Bollinger Band on August 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for GDTC entered a downward trend on August 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GDTC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.253) is normal, around the industry mean (20.126). P/E Ratio (0.000) is within average values for comparable stocks, (52.590). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.088). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (416.667) is also within normal values, averaging (327.236).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GDTC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
GDTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GDTC is expected to report earnings to fall 66.67% to -3 cents per share on November 14

CytoMed Therapeutics Limited GDTC Stock Earnings Reports
Q2'25
Est.
$-0.04
Q4'24
Missed
by $0.08
Q3'24
Est.
$-0.04
Q2'24
Beat
by $0.01
Q1'24
Est.
$-0.04
The last earnings report on May 05 showed earnings per share of -11 cents, missing the estimate of -3 cents. With 2.90K shares outstanding, the current market capitalization sits at 22.65M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Commonwealth Lane
Phone
+65 62507738
Employees
28
Web
https://w2.cytomed.sg
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EJH1.090.03
+2.82%
E-Home Household Service Holdings Limited
TRDA5.290.07
+1.34%
Entrada Therapeutics
IRMD71.99-0.15
-0.21%
iRadimed Corp
AROC25.25-0.19
-0.75%
Archrock
WCN179.30-1.97
-1.09%
Waste Connections

GDTC and Stocks

Correlation & Price change

A.I.dvisor tells us that GDTC and CVKD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GDTC and CVKD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
+1.58%
CVKD - GDTC
31%
Poorly correlated
+5.88%
CYCN - GDTC
30%
Poorly correlated
-7.31%
ADIL - GDTC
30%
Poorly correlated
+0.61%
QSI - GDTC
27%
Poorly correlated
+0.93%
GRCE - GDTC
27%
Poorly correlated
+4.58%
More